Revenue fell 32.2% year-over-year to RMB987.5 million, with gross profit rising to RMB432.3 million due to lower costs, but contracted sales dropped 43.3%. Net loss narrowed to RMB64.4 million, and the company is accelerating its shift from real estate to the health industry amid ongoing liquidity and debt challenges.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.